The Use of the Esclera Scleral Contact Lens in the Treatment of Moderate to Severe Dry Eye Disease.

PURPOSE To evaluate the efficacy of the Esclera scleral contact lens (SCL) treatment and its impact on clinical testing for moderate to severe dry eye disease (DED). DESIGN Prospective interventional case series. METHODS A total of 41 eyes from 25 patients with moderate to severe DED were evaluated for the Esclera SCL treatment. Best-corrected visual acuity (BCVA), tear osmolarity, the Schirmer I test, tear film breakup time (TBUT), corneal and conjunctival staining, meibomian grading, and Ocular Surface Disease Index and SF-36v2 questionnaires were assessed before and after the SCL treatment. These values were compared to assess the real benefit of using SCL as a treatment for DED. RESULTS Forty-one eyes from 25 patients were fitted with SCL for management of DED. The underlying diseases were Stevens-Johnson syndrome (22 eyes), Sjogren syndrome (11 eyes), graft-vs-host disease (2 eyes), dry eye after keratomileusis in situ (2 eyes), and undifferentiated ocular surface disease (4 eyes). BCVA improved from 0.703 ± 0.55 logMAR with habitual correction to 0.406 ± 0.43 logMAR with SCL (P < .001). There was a significant decrease in tear osmolarity values (338.1 ± 27.1 to 314.25 ± 38.8 mOsm/L, P < .001) and van Bijsterveld scores (3.63 ± 2.33 to 2.63 ± 2.46 grade, P = .015) between the baseline and 12 months after SCL wear. There were also significant improvements in dry eye symptoms and quality of life as assessed by the OSDI and SF-36v2 questionnaires (both with P < .001). CONCLUSIONS The Esclera SCL treatment had a positive impact on tear osmolarity and van Bijsterveld score, as well as an improvement in the patients' BCVA, dry eye symptoms, and quality of life.

[1]  D. Jacobs.  Update on scleral lenses , 2008, Current opinion in ophthalmology.

[2]  Angus McFadyen,et al.  Tear film osmolarity: determination of a referent for dry eye diagnosis. , 2006, Investigative ophthalmology & visual science.

[3]  Sanjay V. Patel,et al.  Scleral lenses in the management of ocular surface disease. , 2014, Ophthalmology.

[4]  A. Kheirkhah,et al.  Use of mini scleral contact lenses in moderate to severe dry eye. , 2012, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[5]  A J Bron,et al.  The Doyne Lecture. Reflections on the tears. , 1997, Eye.

[6]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[7]  I. Mandel,et al.  Tear osmolarity variation in the dry eye. , 1986, Transactions of the American Ophthalmological Society.

[8]  R. Buckley,et al.  A study of 530 patients referred for rigid gas permeable scleral contact lens assessment. , 1997, Cornea.

[9]  C. Sherbourne,et al.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .

[10]  J. Chodosh,et al.  Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis. , 2015, Ophthalmology.

[11]  D. Jacobs,et al.  Boston Scleral Lens Prosthetic Device for Treatment of Severe Dry Eye in Chronic Graft-Versus-Host Disease , 2007, Cornea.

[12]  A. Solomon,et al.  The Diagnosis and Management of Dry Eye: A Twenty-five–Year Review , 2000, Cornea.

[13]  J. Baum,et al.  Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. , 2000, American journal of ophthalmology.

[14]  Gerd Geerling,et al.  An objective approach to dry eye disease severity. , 2010, Investigative ophthalmology & visual science.

[15]  M. Lemp,et al.  Management of dry eye disease. , 2008, The American journal of managed care.

[16]  R. Schiffman,et al.  Reliability and validity of the Ocular Surface Disease Index. , 2000, Archives of ophthalmology.

[17]  S. Pflugfelder,et al.  Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease. , 2015, American journal of ophthalmology.

[18]  A. Bron,et al.  Using osmolarity to diagnose dry eye: a compartmental hypothesis and review of our assumptions. , 2002, Advances in experimental medicine and biology.

[19]  P. Rosenthal,et al.  The Boston Scleral Lens in the management of severe ocular surface disease. , 2003, Ophthalmology clinics of North America.

[20]  O. P. Bijsterveld,et al.  Diagnostic Tests in the Sicca Syndrome , 1969 .

[21]  J. González-Méijome,et al.  Modern scleral contact lenses: A review. , 2014, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[22]  R. Buckley,et al.  Therapeutic and ocular surface indications for scleral contact lenses. , 2007, The ocular surface.

[23]  P. Rosenthal,et al.  Fluid-Ventilated, Gas-Permeable Scleral Contact Lens Is an Effective Option for Managing Severe Ocular Surface Disease and Many Corneal Disorders That Would Otherwise Require Penetrating Keratoplasty , 2005, Eye & contact lens.

[24]  B. Munoz,et al.  Dry eye and dry mouth in the elderly: a population-based assessment. , 1999, Archives of internal medicine.

[25]  Claus Cursiefen,et al.  Tear Film Osmolarity Measurements in Dry Eye Disease Using Electrical Impedance Technology , 2011, Cornea.

[26]  A. Bron,et al.  Reflections on the tears , 1997, Eye.

[27]  P Rosenthal,et al.  Gas-permeable scleral contact lens therapy in ocular surface disease. , 2000, American journal of ophthalmology.

[28]  M. Tassignon,et al.  Scleral Contact Lenses as an Alternative to Tarsorrhaphy for the Long-Term Management of Combined Exposure and Neurotrophic Keratopathy , 2013, Cornea.

[29]  Christophe Baudouin,et al.  The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[30]  R. Farris,et al.  Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. , 1979, Archives of ophthalmology.

[31]  A. Gratwohl,et al.  Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT , 2013, Bone Marrow Transplantation.

[32]  J. Kok,et al.  Treatment of Ocular Surface Disorders and Dry Eyes with High Gas-Permeable Scleral Lenses , 1992, Cornea.

[33]  M. Flowers,et al.  Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[34]  Christos Theophanous,et al.  Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson syndrome. , 2014, American journal of ophthalmology.

[35]  K. Tsubota,et al.  Ocular surface changes and discomfort in patients with meibomian gland dysfunction. , 1995, Archives of ophthalmology.